Androgen receptor degradation as a therapeutic modality in castrate resistant prostate cancer
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
Arvinas Inc.
Start Date
July 1, 2015
End Date
December 31, 2015
Administered By
Pharmacology & Cancer Biology
Awarded By
Arvinas Inc.
Start Date
July 1, 2015
End Date
December 31, 2015